GELS (Gelteq) Other Current Receivables: $0.28 Mil (As of Dec. 2025)


GELS Gelteq Ltd GELS
8 GF Score
Price $0.56
! 4 Warning Signs
View Full Analysis

What is Gelteq Other Current Receivables?

Gelteq GELS -5.30% 8 Other Current Receivables is $0.28 Mil as of Dec. 2025. GuruFocus rates GELS with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Gelteq's Other Current Receivables for the quarter that ended in Dec. 2025 was $0.28 Mil.

Gelteq's quarterly Other Current Receivables increased from Dec. 2024 ($0.19 Mil) to Jun. 2025 ($0.27 Mil) and increased from Jun. 2025 ($0.27 Mil) to Dec. 2025 ($0.28 Mil).

Gelteq's annual Other Current Receivables declined from Jun. 2023 ($0.18 Mil) to Jun. 2024 ($0.12 Mil) but then increased from Jun. 2024 ($0.12 Mil) to Jun. 2025 ($0.27 Mil).

Gelteq Other Current Receivables Related Terms

Gelteq Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Gelteq's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Other Current Receivables Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial 0.15 0.17 0.18 0.12 0.27

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 0.00 0.12 0.19 0.27 0.28
GELS
8GF Score
Gelteq Ltd GELS
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gelteq Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.28 Mil mean?
Gelteq (GELS) has a Other Current Receivables of $0.28 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gelteq and its competitors.
Is Gelteq's Other Current Receivables too high?
Gelteq's current Other Current Receivables is $0.28 Mil. Overall, Gelteq has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Other Current Receivables compare to YCBD and AKAN?
Gelteq's Other Current Receivables of $0.28 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gelteq and its competitors. Gelteq's current Other Current Receivables is $0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Other Current Receivables of $0.28 Mil. The current Other Current Receivables is $0.28 Mil. Gelteq's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Gelteq (GELS), the current Other Current Receivables is $0.28 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
8GF Score

Get the complete analysis for GELS

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price